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ABSTRACT 
 
 
Genetic Analysis of Dilated Cardiomyopathy in the Great Dane. (December 2007) 
 
Stephanie Michelle Herbst, B.S.; B.S., Texas A&M University 
 
Chair of Advisory Committee: Dr. Keith E. Murphy 
 
 
The domestic dog, Canis familiaris, with over 450 naturally-occurring hereditary 
diseases, serves as a valuable model organism for study of the genetics underlying many 
human hereditary diseases. Approximately half of the diseases that afflict the dog are 
clinically very similar to various human hereditary diseases. Several cardiac diseases are 
in this category. Our laboratory is interested in cardiac diseases because they are   
common causes of death in the human and are also a widespread problem in many 
breeds of dog. The specific focus of my work is on understanding the genetics of dilated 
cardiomyopathy (DCM). 
DCM is a disease characterized by enlargement of the left ventricle leading to an 
inability of the heart to pump sufficient blood to the body. It is one of the most common 
cardiac diseases in the dog and has a high mortality. The Great Dane is the second most 
commonly affected breed. It is seen in many families of Great Danes, and this suggests 
that DCM has a genetic component. The mode of inheritance of DCM in the Great Dane 
is currently unknown, although studies have reported both autosomal recessive and 
autosomal dominant transmission.  
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Many different genes cause DCM, indicating the complexity of the disease. 
These typically produce proteins that are involved in the sarcomere or cytoskeletal 
components, leading to problems with contraction or cardiac cell integrity.  
In order to identify causative or susceptibility genes for DCM in the Great Dane, 
a whole-genome linkage screen was conducted in a family of Great Danes. One 
candidate gene, gamma-sarcoglycan (SGCG), was identified through linkage and 
sequenced in affected and unaffected dogs. Sequencing data revealed no mutations in the 
coding regions of SGCG, most likely excluding it as a candidate gene for DCM. 
Continued evaluation of this gene and others, both in sequence content and additional 
properties such as epigenetic effects, protein structure, and interaction with other genes 
will increase understanding of DCM in both the dog and the human.  
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CHAPTER I 
INTRODUCTION 
 
Evolution of the dog 
The domestic dog, Canis familiaris, has origins in East Asia, where it diverged 
exclusively from the gray wolf1-3. The exact point at which this divergence occurred, 
however, has proven difficult to establish. The modern dog, consisting of over 1000 
different recognized breeds throughout the world4,5, has developed within the last several 
hundred years and was, in fact, the first animal to be domesticated6,7. However, there are 
different estimates of the age of the dog in general, and even whether its relationship 
with humans occurred as a single event or was the result of multiple individual 
domestication events8. Because the dog exhibits more genetic diversity than would be 
expected from a single domestication event such as a genetic bottleneck, it is possible 
that multiple backcross events, such as that between a more domestic dog and a non-
domesticated relative, occurred during the domestication process 7,8. Furthermore, the 
striking level of phenotypic diversity found in the dog suggests pronounced genetic 
variability of its ancestors, which indicates a more diverse origin9.  
Wayne and Vilà compared mitochondrial DNA sequence variation between 
wolves and dogs and suggested that the modern dog came into existence approximately 
135,000 years ago1,10,11. Savolainen argued for a more recent domestication that occurred 
approximately 25,000 years ago resulting in the dog as it is known today1,10. In contrast 
____________________ 
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to mitochondrial DNA evidence, however, the earliest accepted fossils of modern dogs 
found in Germany, Israel, and Iraq date to 12-14,000 years ago3. 
 
Canis familiaris as a model organism 
Since its domestication, the dog has played a number of roles in the lives of 
humans. It has an important role in biomedical research and is particularly useful for 
genetic studies. The dog is widely known, both currently and historically, to be man’s 
companion and, as such, shares much of the same environment as humans, including 
living quarters and food sources. This allows the dog to be evaluated in the same context 
as the human and eliminates the need to control for environmental differences between 
the two. In addition, since the advent of breed clubs and registries such as the American 
Kennel Club (AKC), it is easy to assemble information such as breed records and 
multigenerational pedigrees12. Breed clubs exist, in part, to ensure that breed standards 
are maintained. This is exemplified by the “breed barrier” rule, a requirement of the 
AKC that both parents of a particular dog be registered within the same breed12. Thus, 
each breed represents a closed breeding population. Because of this, the domestic dog 
has become an important model organism for the study of hereditary diseases. 
There is a level of phenotypic diversity in the dog that is not found in any other 
mammal5,11. Selective breeding practices maintain phenotypic characteristics of 
individual breeds, including size, coat color and texture, and body shape. Furthermore, 
the strict breed standards ensure reproductive isolation between breeds12. This closed 
gene pool between breeds allows each breed of dog to be studied as individual isolated 
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populations12,13. Due to extensive inbreeding, the popular sire effect, population 
bottlenecks and founder effects, more than half of the hereditary diseases that afflict the 
domestic dog are restricted to one or only a few breeds2,13.  
The breeding practices necessary to maintain breed standards have resulted in the 
selection for hereditary diseases in the dog, of which there are more than 45014, with new 
diseases reported every year15. Most of the diseases are inherited in an autosomal 
recessive fashion16, and become more prevalent when the high levels of inbreeding seen 
in most breeds of dog produce more affected dogs as a result of two asymptomatic dogs 
carrying the recessive alleles being bred together. About half of the hereditary diseases 
found in the dog are represented in the human, as well, with clinical similarities between 
the two14. Therefore, the dog serves as an excellent natural model of human hereditary 
diseases, eliminating the need for induced models, such as transgenic models made in 
the mouse or rat, which have historically been the most popular model systems in which 
to study human diseases. In fact, sequence similarity between the human and dog is at 
least twice that found between the mouse and either the human or the dog17,18. Thus, 
using the dog as a model system provides the opportunity to more fully evaluate 
hereditary diseases in humans, because the dog is evolutionarily closer to the human 
than is the mouse. In addition, drug safety and gene therapy trials have also successfully 
demonstrated the utility of the domestic dog in areas other than hereditary diseases17. 
The dog has several additional qualifications that also make it a useful model 
system.  The medical care available for the domestic dog is second only to that available 
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for the human13,15,17. In addition, dogs are able to be crossbred easily, and have short 
gestation times and large litter sizes relative to the human.  
 
Resources available for canine genetics research 
The canine genome consists of approximately 2.5 billion base pairs2, which is 
slightly smaller than the size of the human genome (2.9 billion base pairs). The 
estimated number of genes is similar for both, approximately 20-25,000. The dog has 38 
pairs of acrocentric chromosomes and metacentric sex chromosomes, for a total of 78 
chromosomes. Many of the canine chromosomes are very similar in size and 
morphology, with only slight differences in size, making their distinction difficult19. The 
first 21 chromosomes, as well as the X and Y chromosomes, were identified in 1996 by 
Switonski, et al., with the use of G-banding techniques20, while the remaining 
chromosomes were not definitively identified until 1999 by Breen, et al., with DAPI 
banding of chromosome-specific paints21.   
The proven utility of the dog for study of genetics, and specifically as a model 
for human hereditary diseases14, resulted in its selection for genomic sequencing. The 
first draft of the sequence of the canine genome was completed in 2002 by Kirkness, et 
al. of a male standard poodle22. It consisted of 6.22 million sequence reads and provided 
1.5x coverage of the canine genome. Even though this sequence effort represented only 
approximately 78% of the canine genome, it was determined that there is significant 
nucleotide conservation between the dog and other mammalian genomes, specifically, 
more so between the dog and the human than between the human and the mouse10. In 
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fact, the 1.5x sequence of the dog was found to annotate more human genes than the 8x 
murine genome sequence17. The sequence also revealed that the canine genome 
consisted of approximately 31% repetitive sequences such as microsatellite DNA and 
SINE sequences, which are useful in mapping of disease genes10.  
The presence of large gaps in the genome sequence of the poodle led to a second 
sequencing effort of the canine genome, which was completed in 2004. A female Boxer 
was selected for sequencing after determining that she exhibited the smallest amount of 
genetic heterogeneity and would, therefore, best represent the canine genome in 
general23,24. This sequencing effort produced a total of 31.5 million sequence reads for 
sequence coverage of 7.5x and is publicly available online at the website of the National 
Center for Biotechnology Information (NCBI), http://www.ncbi.nlm.nih.gov/ 2. This is 
estimated to cover approximately 99% of the genome, with approximately 1% of the 
genome remaining as gaps in sequence. These sequence data suggested that the coding 
portions of the genome of the dog are approximately 18% smaller than the coding 
regions of the human and only 6% smaller than that of the mouse. This difference is 
likely due to the lower rate of insertions in the canine genome relative to both the human 
and mouse25.  
In addition to the genome sequence, the generation of dense marker maps has 
expedited the search for disease genes. Linkage maps have progressed from the first 
generation linkage map, which included 43 microsatellites placed into 16 linkage 
groups26, to the current best tool for conducting linkage studies, the MSS-3, which is a 
set of 510 microsatellite markers evenly spaced throughout the canine genome. The 
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MSS3 allows genome screens in the dog to be conducted at a resolution of 
approximately 5 cM27.  
 
Methods for finding disease genes  
There are three common methods that are used in studies of hereditary diseases. 
First, the candidate gene approach is used when a causative gene is known in another 
species. The orthologous gene is located in the dog and analyzed for causative 
mutations. This method is well-suited for comparative studies of hereditary diseases in 
the dog, because the analytical tools are now available and widely used. This method has 
successfully been used to find the causative gene for many canine diseases. A 
disadvantage of the candidate gene approach is the significant investment of time and 
resources that often result in negative results, i.e. exclusion of genes28. For this reason, 
the candidate gene approach is feasible for diseases that have few possible genes, but 
less useful for complex, polygenic diseases, due to the large numbers of genes that must 
be analyzed.  
Linkage is the study of coinheritance of alleles. Genes that are located near one 
another tend to be inherited together as a haplotype. This can be exploited in the search 
for disease genes because microsatellite sequences that are coinherited with a disease 
gene can identify regions in the genome that are linked to a disease phenotype and 
therefore potentially harbor causative mutations. There are two types of linkage analyses 
that can be conducted, classical linkage studies and linkage disequilibrium, or 
association studies. The purpose of these studies is to identify genomic loci that are 
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involved in a trait without any assumptions as to the genetic mechanism at work for the 
trait29. Because loci, and not particular genes, are identified, fine mapping can be done to 
further narrow the region of interest. Classical linkage utilizes a pedigree that consists of 
informative breedings so as to enable the study of transmission of the various alleles of a 
marker. For studies of hereditary diseases, this requires a multigenerational pedigree of 
dogs, both affected and unaffected, and the ability to analyze transmission of alleles so 
as to be able to assess differences between affected and unaffected individuals. 
Furthermore, classical linkage analysis assumes that the mutation causative for the 
disease occurred as a founder event in the population or breed. Also, it is assumed that a 
finite number of recombination events have occurred in the pedigree in order to increase 
the chances of finding linkage. This approach resulted in identification of the genes for 
several monogenic hereditary diseases, including cystic fibrosis and Huntington’s 
disease29. Genetically heterogeneous traits, on the other hand, may not be well-suited for 
linkage studies, because it is difficult to determine mode of inheritance when there is 
more than one contributing locus. 
Linkage disequilibrium (LD) is the method of choice when the population 
consists of random, unrelated dogs that are separated by a minimum of three generations. 
This method is often employed in studies of the dog due to the difficulty in obtaining 
enough related dogs from a pedigree for studies of a particular disease. Due to the 
random nature of the participants in an LD study, it is assumed that there are a 
potentially unlimited number of recombination events that have occurred since the first 
appearance of the disease in the population. This unlimited number of recombination 
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events essentially “breaks” the genome into smaller and smaller pieces, reducing the size 
of the haplotype blocks that are inherited from generation to generation. This increases 
the likelihood of finding linkage to a disease gene, especially because LD also assumes 
that the mutation occurred as a founder event in the population or breed. A disease-
causing mutation that occurred many generations ago and lies in close proximity to a 
genetic marker will most often be coinherited with that marker, leading to a population-
wide association. This phenomenon is easily explained by the fact that the population 
has a shared common ancestry30. In essence, if all dogs in a breed that are affected with 
the same hereditary disease harbor the same mutation, the value for LD will be higher. In 
short, if a genotype is truly linked to a disease in a population, it will be found more 
often in affected individuals than in unaffected individuals. LD analysis, however, is a 
more difficult method to employ in the study of rare, complex diseases, because of the 
requirement of a large number of affected individuals, which is often not possible to 
obtain. 
A third approach to identification of potential disease-causing genes is 
microarray analysis. Probing of microarrays is done in order to measure mRNA levels. 
This method has been used to identify candidate genes for hereditary diseases of dogs. 
Microarray analyses have typically been performed on cDNA oligonucleotide arrays to 
detect homology between transcripts.  However, it is now possible to perform analyses 
on arrays containing tens of thousands of single nucleotide polymorphisms (SNPs), a 
method which will, in theory, combine both linkage studies and microarray studies. 
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These SNP arrays consist of a very large number of SNPs that are present in the canine 
genome and can be used for linkage studies of hereditary diseases.  
 
Dilated cardiomyopathy 
A common cause of death for humans and dogs is cardiac disease. One such 
cardiac disease is DCM. DCM is the most common type of cardiomyopathy, and 
accounts for about 60% of all human cases31. DCM was first described in 1970 by 
Ettinger, Bolton, and Lord as congestive heart failure (CHF) with dilation of the heart in 
the absence of other cardiac disease32. In humans, DCM is the leading reason for cardiac 
transplant33. DCM is a chronic progressive disease of the cardiac muscle that causes 
enlargement of the left, and sometimes right, ventricle34. This enlargement impairs the 
systolic function of the heart and results in the inability of the heart to pump sufficient 
blood to the body. DCM affects several large breeds of the domestic dog, including the 
Doberman pinscher, Great Dane, Boxer, Portuguese water dog, and Irish Wolfhound35. 
The Great Dane has the second highest incidence of DCM and is the main focus of this 
dissertation.  
DCM is a heterogeneous disease, in both clinical manifestation and genetic 
causes36. Typically, DCM is an adult-onset disease in the dog. However, age of onset 
and possible contribution from environmental factors make it more difficult to identify 
affected individuals28. Additionally, affected individuals often reproduce before being 
identified, thereby propagating the disease. There are childhood onset forms of DCM in 
the human, but the Portuguese water dog is among the few breeds reported to have early-
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onset forms of DCM37. Symptoms can include coughing, shortness of breath, exercise 
intolerance, syncope, cardiac arrhythmias, specifically atrial fibrillation, premature 
ventricular contractions (PVCs), or even sudden death.   
There are two commonly recognized stages of DCM. Preclinical DCM is the 
stage during which cellular changes begin to occur. During this period, dogs do not show 
clinical signs of DCM. Preclinical DCM may be brief for some dogs, but in others it can 
last for years. For these latter dogs, normal arterial blood pressure, resistance, blood 
flow, and oxygen delivery to the tissues are observed38. Preclinical DCM is best 
diagnosed through echocardiography, which assesses systolic and diastolic function and 
provides estimates of filling pressures for both sides of the heart39. The second stage, 
overt DCM, is when most diagnoses are made. At this point, the typical clinical signs 
and symptoms of DCM are evident. This stage is also the most difficult to treat, due to 
extensive reduction in cardiac function. The prognosis for dogs with overt DCM is grim, 
with survival times ranging from weeks to months. However, early intervention and 
treatment may halt progression of the disease and prevent sudden death40. Dogs with 
DCM eventually progress to CHF if sudden death does not occur34.  
DCM is characterized by several common clinical features. Diagnosis of DCM 
requires pronounced dilation of the left, and possibly right, ventricle, compromised 
systolic function, and increased sphericity of the left ventricle41. As the disease begins, 
cardiac cells cease normal function in order to maintain the pumping efficiency of the 
heart and tissue perfusion38,42. These changes eventually become maladaptive and begin 
to promote ventricular remodeling, death of cardiac cells, and fibrosis of affected cardiac 
 11 
tissue. This, in turn, causes a decrease in the systolic and diastolic function and 
eventually leads to cardiac failure.  
Two distinct histopathological findings are common in canine DCM. These are 
attenuated wavy fibers, and fatty infiltration. The attenuated wavy fiber type of DCM is 
characterized by thinner myocytes that have a wavy appearance and are separated by 
clear spaces indicative of fluid. This is typically found in large breed dogs such as the 
Great Dane and Irish wolfhound and supports the theory of cytoskeletal elements being 
involved in DCM. Detection of attenuated wavy fibers in the myocardium has been 
reported to be reliable for detection of DCM32. The fatty infiltrative type of DCM is 
typically found in Boxers and some Doberman pinschers and is characterized by 
myocytolysis, degeneration of myofibers, and atrophy of myocytes with fibrosis and 
fatty infiltration that replaces the myofibers41. These findings are thought to precede 
clinical symptoms, and may reflect the earliest stages of DCM 32. 
 
Etiology and inheritance of DCM 
DCM is caused by many different factors. These can include, but are not likely 
limited to, nutritional deficiencies, viral causes, problems with immune function, toxins, 
including alcohol, and genetic causes43.  Studies of human DCM show that most cases 
(47%) are idiopathic44. However, familial cases of DCM are also known, and estimated 
to account for up to 30% of human DCM31. Determination of the mode of inheritance of 
DCM in a population has proven difficult, and is made more difficult by possible 
 12 
incomplete penetrance, variable expressivity, and modifier genes that either enhance or 
suppress the function of the causative allele28.  
The most common reported mode of transmission is autosomal dominant. This 
accounts for 56% of human familial DCM45. However, autosomal recessive, X-linked, 
and mitochondrial modes of inheritance have been reported in the human, as well44. In 
the domestic dog, familial DCM has been reported in the Doberman pinscher, Boxer, 
and Portuguese water dog35. Autosomal recessive inheritance of DCM is uncommon46 
but has been reported in the Portuguese water dog as a juvenile onset form of DCM 47. 
X-linked DCM has been reported in the human36, but convincing evidence of X-linked 
DCM in the dog is lacking35,48.  
 
Genes involved in DCM 
Prior to the discovery of causative genes, many regions of the human genome 
were linked to DCM.  Traditional linkage studies have identified many loci that are 
linked to autosomal dominant DCM in humans, including 1p1-1q149, 1q3250, 3p22-
p2533, 10q21-2331, 9q13-q2251, and 6q2352. X-linked DCM in humans was found to be 
linked to Xq2853 and Xp21, which harbors the dystrophin gene. Mutations in the 
dystrophin gene cause DCM and are, of course, causative for Duchene Muscular 
Dystrophy49. Also, Barth syndrome, is a disease caused by mutations in the Tafazzin 
(TAZ) gene. Tafazzin mutations result in a highly lethal form of cardiomyopathy46.  
The role of mitochondria in DCM has been investigated, due to the extremely 
high energy requirements of cardiac cells. Mitochondrial mutations have been known to 
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cause DCM, but typically not without the involvement of other organ systems, as well49. 
Furthermore, while no causal relationships have been established for DCM and 
mitochondrial mutations, it is thought that SNPs in mitochondria-encoded genes may be 
associated with a predisposition to non-familial DCM in some human populations54.  
Once different regions were found to be linked to DCM, individual genes causing 
DCM in particular populations were identified. These are typically determined to be 
components of the cytoskeleton or sarcomere, although some genes produce DCM 
through unknown molecular mechanisms. Many different mutations lead to the clinical 
symptoms of DCM, indicating the level of complexity and genetic heterogeneity of the 
disease45. The list of genes implicated in human DCM is extensive and includes: 
sarcomere proteins troponin T (TnT)55,56, troponin I (TnI), troponin C (TnC), cardiac 
actin57, β-myosin heavy chain (β-MHC), myosin binding protein C (MyBP-C), and α-
tropomyosin; cytoskeletal proteins desmin58, δ-sarcoglycan, vinculin, and titin; and 
nuclear envelope protein lamin A/C45,59. Xq28 harbors G4.5, which was determined to 
be the causative gene for Barth syndrome60. G4.5 encodes many different mRNAs that, 
through differential splicing, produce different proteins called tafazzins. Barth syndrome 
results when point mutations introduce premature stop codons to produce truncated 
proteins. The other identified form of X-linked DCM results from mutations in the 
dystrophin gene, which is a cytoskeletal protein important in cardiac function. 
Dystrophin acts to maintain connections between the sarcomere and the cytoskeleton, 
stabilizing the cardiomyocytes.  
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Discovery of a causative gene or genes for DCM would allow the development 
of a DNA-based test for the disease. For the domestic dog, this would enable breeders to 
identify affected and carrier dogs, and to eliminate them from the breeding pool. This 
could serve to largely reduce or even eliminate the disease in a breed. 
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CHAPTER II 
WHOLE GENOME SCREEN TO DETECT LINKAGE OF DILATED 
CARDIOMYOPATHY IN A FAMILY OF GREAT DANES 
 
Introduction 
 Dilated cardiomyopathy (DCM) is a condition observed in the Great Dane, 
Boxer, Doberman pinscher, Portuguese water dog, and other breeds of Canis familiaris, 
the domestic dog. The Great Dane is the second most commonly affected, with a 
prevalence of 3.9%61. DCM is the most common form of canine primary cardiovascular 
disease, accounting for approximately 60-87% of all cardiomyopathy cases62. Typically, 
the disorder is characterized by progressive enlargement of the left ventricle and 
consequential inhibition of the heart’s ability to pump blood throughout the body. Over 
time, chronic disruption of proper blood flow and the associated sub-optimal 
oxygenation of tissues lead to arrhythmias, coughing, syncope, ascites, and, in more 
severe cases, congestive heart failure and sudden death63. 
 Veterinarians typically recognize two distinct clinical stages of DCM. The 
preclinical stage is highly variable in duration and refers to the etiologic period when 
signs and symptoms are not noticeable upon routine examination. Overt DCM refers to 
the window of time when clinical signs and symptoms emerge and the debilitating health 
effects of the disease become readily apparent in affected animals.  Typically, diagnoses 
are made in the overt stage, when dogs are between four and six years of age64,65. 
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 As one might expect, disease detection and intervention are most beneficial to 
affected animals during the preclinical stage when palliative medications, designed to 
maintain the pumping action of the heart and eliminate excess fluid caused by impaired 
cardiac function36, have the greatest impact on quality of life and long-term survival. As 
such, a genetic test for DCM would be valuable, especially in breeds such as the Great 
Dane in which the disorder imposes considerable physical, emotional, and economic 
burdens on dogs and their owners. Several studies are attempting to identify causative or 
susceptibility genes that influence disease onset and severity in different breeds. 
 The prevalence of DCM in several breeds of the dog, as well as the fact that 
DCM is notably rare in cross breeds, suggests a genetic basis66. While several different 
patterns of inheritance for DCM have been reported in the dog36,66,67, the inheritance of 
DCM in the Great Dane has not yet been determined, although one theory proposes that 
it is inherited in an X-linked recessive fashion, at least in some families68. Furthermore, 
the complex nature of cardiac diseases, which do not obey traditional Mendelian 
genetics, means that they are likely to be the result of multiple inherited and 
environmental factors30 and complicated by incomplete penetrance and variable 
expressivity69.   
 While analyses in this study did not yield compelling support for Mendelian 
transmission or significant linkage, positive LOD scores were identified for eight 
markers spread across six canine chromosomes. One such marker, FH2324, is a 
microsatellite located proximal to the gamma-sarcoglycan gene (SGCG) on chromosome 
25. SGCG is a member of the sarcoglycan complex of transmembrane proteins that 
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associate with dystrophin to connect the cytoskeleton to the extracellular matrix in 
skeletal and cardiac muscle70. This finding prompted sequencing of the coding region of 
SGCG and evaluation of its role as a potential candidate gene for DCM. The sequencing 
results indicated that SGCG does not harbor a causative mutation in our population, and 
therefore it was excluded as a candidate gene for DCM in the Great Dane.  
 
Animals, materials and methods 
Experimental Population 
 For this study, 25 client-owned Great Danes were evaluated. The dogs are from a 
family consisting of four generations and six individuals diagnosed with DCM by a 
board-certified veterinary cardiologist (see Figure 1). All clinical information and 
biological samples (blood or buccal swab) were collected for each dog following 
university regulations. Diagnoses of DCM were based on echocardiography, the 
AVMA-approved diagnostic criterion for DCM64. 
 
  
 
 
 
 
 
Figure 1.  Experimental pedigree for linkage study of DCM in the Great Dane.   
06/21/2007
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Pertinent anthropometric and physiological measures included the internal 
diameter of the left ventricle at systole and diastole, the percentage of fractional 
shortening of cardiac cells, and the ejection fraction of blood. Dogs who were diagnosed 
with DCM typically exhibited 1) an increased internal diameter of the left ventricle 
during both systole (LVDs) and diastole (LVDd), indicating the thickness of the cardiac 
muscle, 2) a reduced ejection fraction, the extent to which the amount of blood is 
pumped from the left ventricle, and 3) a reduced percentage of fractional shortening (FS) 
relative to normal. FS is a ratio of the difference in the diameter of the left ventricle 
between the contracted state (systole) and the relaxed state (diastole) (see Table 1), and 
is used in most canine studies as the major indicator of systolic function41.  
 These measurements served as the basis to quantify the aggregate pumping 
capacity of the heart and whether this ability had been compromised in a manner 
characteristic of DCM. Normal values for Great Danes were reported by Koch, et al. to 
be as follows: LVDs of 3.95 cm, LVDs of 5.3 cm, and FS of 25%34. All diagnoses were 
made by qualified veterinary cardiologists. 
 
Table 1. Echocardiographic measurements in 
dogs with (n=6) and without (n=15) DCM. 
P-values: 1.3x10-6 for LVDs, 6.5x10-7 for LVDd, 
and 1.9x10-3 for FS 
 Great Danes 
with DCM 
Great Danes 
without DCM 
LVDs (cm) 5.66 ± 1.04 3.55 ± 1.06 
LVDd (cm) 7.30 ± 0.8 5.50 ± 0.54 
FS (%) 21.3 ± 7.9 35.4 ± 14.6 
LVDs, diastolic left ventricular diameter; 
LVDd, systolic left ventricular diameter; FS, 
fractional shortening 
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Complex Segregation Analysis 
iBay v1.1 (Janss, 2006) was used to assess the contribution of a major genetic 
factor to DCM transmission in the experimental population. As described elsewhere71, 
iBay implements a hierarchical Bayesian approach to CSA that harnesses Markov chain 
Monte Carlo (MCMC) estimation and Gibbs sampling procedures to generate posterior 
density distributions and Bayesian factors for key model parameters. The approach 
enables simultaneous evaluation of a putative Mendelian locus and estimation of the 
posterior density for a polygenic contribution to DCM. Moreover, and in notable 
contrast to most statistical genetic algorithms available for segregation analysis, iBay 
supports the use of general pedigrees with multiple generations and inbreeding loops, 
thus ameliorating the potential loss of power associated with “cutting” kindreds into 
smaller subsets comprised of “loop-free” nuclear families. 
 
Linkage Study 
Whole blood or buccal swabs were collected for each Great Dane in the 
experimental population. Samples were submitted and DNA was extracted using the 
Puregene DNA Isolation Kit (Gentra Systems, Minneapolis, MN).  
For this study, a multiplexed set of canine microsatellite markers, the Minimal 
Screening Set-2 (MSS-2)72, was used. The MSS-2 consists of 327 microsatellite markers 
located throughout the canine genome. It includes 171 tetra-, 151 di-, and three tri-
nucleotide repeats that are multiplexed into 69 sets for ease of amplification73. The 
average spacing between MSS-2 markers is nine Mb.  
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Genotyping of each dog was carried out as described elsewhere73. Briefly, MSS-
2 primers were used to amplify canine microsatellites by the polymerase chain reaction 
(PCR). PCR products were resolved on an ABI 3730x1 DNA Analyzer (Applied 
Biosystems, Foster City, CA). The GeneScan 500 LIZ internal size standard (Applied 
Biosystems) was used. Genotypes were scored using Genemapper® Software v3.5 
(Applied Biosystems). 
Two-point LOD scores were calculated with the use of the SOLAR (Sequential 
Oligogenic Linkage Analysis Routines) software package. A total of three traits were 
used for statistical analyses, including LVDs, LVDd, and FS. The ejection fraction was 
not used as a trait, because it is not routinely measured during echocardiography and was 
not available for all dogs. 
 
Sequencing of SGCG  
 Three Great Danes with DCM and two without DCM were selected for 
sequencing. Because DCM is an adult-onset disease, unaffected subjects were selected 
from the oldest dogs (8 years and 11 years) in our pedigree. In addition, an unaffected 
mixed-breed dog from a pedigree with no history of cardiac disease was sequenced as a 
control. 
Primers were designed for each of the seven coding exons of SGCG in order to 
amplify the entire exons and to capture the intron-exon boundaries and partial intronic 
sequences, as well (see Table 2). Sequencing reactions were carried out in a volume of 
20µL consisting of 0.25 units/µL Taq DNA polymerase with 1.2X Buffer B (Fisher 
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Scientific, Pittsburgh, PA), 1.5 mM MgCl2, 1x MasterAmp PCR Enhancer (Epicentre 
Technologies, Madison, WI), 1 mM dNTPs, 0.5 µM each of forward and reverse 
primers, and 2.5 ng/µL DNA. All exons were amplified by: 5 min at 95°C followed by 
35 cycles of 1 min at 95°C, 30 sec at optimum primer annealing temperature (see Table 
2), and 1 min at 72°C, with a final extension of 10 min at 72°C. 
Sequences were aligned with the publicly available Boxer sequence using 
ClustalW (http://www.ebi.ac.uk/clustalw/). It is important to note that, while the Boxer 
is among the breeds of dog that are afflicted with DCM, the publicly available Boxer 
sequence was obtained from a healthy Boxer with no evidence of DCM. 
 
Table 2. Canine SGCG Primers 
Primer  Forward Primer (5’-3’) Reverse Primer (5’-3’) Optimum 
Anneal 
Temp (°C) 
Product 
Size (bp) 
SGCGEx2 TATGGTCACTGGATTTC ATGATGTGATACAACAAG 45° 635 
SGCGEx3 GCATCTGTAATCCC GAGTGTAACAGCAATG 43° 310 
SGCGEx4 GATCTGTGACTATGGAG CTATTCTCTGTGGTC 43° 358 
SGCGEx5 CTGACACTACATATAG AGTTCTCATCATAAG 38° 348 
SGCGEx6 GCTTTATGCCTGCCTTG GATCTGGTAATGACTGC 49° 497 
SGCGEx7 CTGCCATCTGAAACTAC CATCAGGACATACAAC 45° 435 
SGCGEx8 CAACCTGTCTGGAGC GTGTCTAATAATGTGC 45° 477 
 
 
Results 
Complex Segregation Analysis 
The results of CSA do not support transmission of a major genetic locus in this 
extended pedigree of Great Danes (data not shown). The 95% highest density regions 
(HDR) for both polygenic and major gene variance were zero, and the Bayes Factor 
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(logBF) estimated for the fitted mixed model was low enough to be considered “not 
worth mentioning”71. 
 
LOD Scores from Linkage Study   
All dogs were genotyped at 324 loci, 314 of which are represented in the MSS-2 
marker set. Remaining markers from the MSS-2 could not be amplified, or their 
genotypes were uninformative for linkage. Ten additional markers were added to the set 
to fine map regions for which positive LOD scores were obtained. The maximum LOD 
scores are displayed in Table 3, including eight markers on six chromosomes.  
 
Table 3. Markers producing positive LOD scores 
Marker Name Chromosome LOD Score 
FH2132 CFA02 1.6 
FH2608 CFA02 1.0 
REN162C04 CFA07 1.2 
C09.173 CFA09 1.1 
FH2885 CFA09 1.1 
FH2324 CFA25 1.1 
FH2585 CFA28 1.0 
RVC11 CFA31 1.1 
 
 
Sequencing of SGCG  
 The seven coding exons of SGCG were amplified and sequenced, along with 
portions of the intronic sequences and the intron-exon boundaries. No sequence 
differences were found between affected and unaffected dogs, in the unaffected mixed-
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breed dog, or between the coding sequence of the Great Dane and the publicly available 
7X Boxer sequence.  
 
Discussion 
DCM is a cardiac disease that results in dilation of the left ventricle of the heart, 
inhibition of proper blood flow throughout the body, and high mortality of affected 
dogs62. The mode of inheritance and specific causes of the disorder are unknown at 
present, although one study has suggested that the disorder may be caused by a viral or 
bacterial agent62. In this study, segregation, linkage, and sequencing analyses were 
conducted in an extended pedigree of Great Danes in an effort to identify genetic factors 
that play a role in DCM pathogenesis. 
 CSA can be performed on a pedigree of related individuals in order to evaluate 
the transmission of a trait of interest from generation to generation74. Results from CSA 
suggest that DCM is not likely to be inherited in a simple Mendelian fashion and might 
best be interpreted as a complex, multi-factorial disease whose onset and severity is 
dictated by multiple genetic, environmental, and behavioral factors. That stated, the 
modest size of the research population must temper conclusions. Also, results for CSA 
may change if larger, more informative families with more affected individuals were 
available for future analyses. 
Linkage studies of more than 200 markers have failed to detect linkage between 
DCM and specific chromosomal regions in the Newfoundland75. Work here for linkage 
analysis of 25 related Great Danes was conducted with the hope of identifying candidate 
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gene regions that might cause or predispose individuals to be affected with DCM. There 
were positive LOD scores for eight markers located on six different chromosomes. None 
of the estimated LOD scores met or surpassed the classical threshold of statistical 
significance (LOD ≥ 3.0). However, given the sample size and implemented model 
specifications, the maximum possible LOD appears to be 1.5, perhaps indicating that 
these results may actually be suggestive of linkage.  
Canine chromosome 2 exhibits sequence homology with human chromosomes 1, 
5, 10, and 1616. Interestingly, the region for which the highest LOD score of 1.6 was 
obtained has no corresponding conserved segments in the human and has not yet been 
completely annotated in the dog, preventing further analysis. It is possible that this 
region is canine-specific and therefore unique to the dog, making it a good candidate for 
further investigation, since it may harbor new, interesting sequences that play a role in 
the disease process of DCM. 
The six chromosomes listed in Table 3 were further investigated to determine 
whether any candidate genes were located close to each linked marker. One gene, 
SGCG, consisting of eight exons, the first of which is non-coding, is located 
approximately 1.6 Mb from FH2324 on CFA25. SGCG mutations were previously 
identified by Noguchi, et al. (1995) as causative of the severe childhood autosomal 
recessive muscular dystrophy (SCARMD), a disease that results in skeletal muscle 
anomalies and cardiomyopathy of affected patients44. In addition, Hack, et al. (1998) 
reported cardiomyopathy development in SGCG-deficient mice76.  
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Based on this, the seven coding exons, the intron-exon boundaries, and portions 
of the intronic sequences of SGCG were sequenced. No sequence differences 1) between 
affected and unaffected Great Danes or 2) between Great Danes in the experimental 
population and the publicly available 7X Boxer sequence were found. These findings 
appear to exclude sequence variation within the coding regions and intron-exon border 
regions of SGGG as the cause of DCM in the Great Dane.  
This study did not evaluate non-coding or regulatory regions of SGCG, or the 
potential contribution of aberrations of protein structure and function. Certainly it would 
be advantageous to verify the presence of the functional protein product of SGCG 
through western blotting or immunohistochemical staining. In addition, mRNA levels 
could be determined for both affected and unaffected dogs in order to determine if 
transcripts are produced. Promoter regions and binding sites for transcription factors 
could be evaluated for mutations that alter promoter function.  
Recently, an array containing over 50,000 SNPs has become available through 
Affymetrix, enabling genome wide comparisons of SNPs between different DNA 
samples. Evaluating such a large number of SNPs in DNA from affected and unaffected 
dogs would greatly increase the likelihood of finding linkage to causative or 
susceptibility genes. One drawback of this approach, however, is the requirement of a 
large number of affected dogs.  For complex diseases such as DCM, a minimum of 100 
affected and 100 unaffected dogs is required. However, if such a sample size were 
feasible, SNP analysis would be an excellent option. 
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Genetic analysis of inherited diseases is complicated when there is no simple 
pattern of inheritance. In fact, complex traits rarely follow simple Mendelian inheritance, 
due to the possibility of many contributing genes or loci and interactions with 
environmental factors. These contributing loci, also called quantitative trait loci (QTLs), 
are not easily mapped with simple mapping, due to their distribution throughout the 
genome. QTL mapping typically assumes equal contribution of all loci involved in the 
trait. Since this cannot be accurately assessed for inherited diseases that have genetic and 
environmental factors, it is not always feasible. Further, QTL mapping is an approach 
reliant on phenotypic characterization. Since DCM is an adult-onset disease, phenotypic 
characterization is often unreliable for animals that are younger than the typical age of 
onset. 
 
Conclusions 
 This work has identified eight chromosomal regions that may influence DCM 
risk in Great Danes. Continued evolution and expansion of the canine genome map will 
no doubt lead to expanded linkage marker sets, and use of single nucleotide 
polymorphism array technology will accelerate identification of loci that are associated 
with various hereditary diseases. Future studies will focus on the acquisition of 
additional families, collection of more expansive clinical and genotype data, and use of 
SNP arrays to dissect the complex nature of canine DCM. 
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CHAPTER III 
CONCLUSIONS 
 
Studies of the domestic dog have revealed causative genes for many hereditary 
diseases. Because of the similarity of the genomes of the dog and human, it is possible to 
utilize information discovered through studies of canine hereditary diseases and apply 
them to studies of hereditary diseases that afflict humans. DCM causes death in both the 
dog and human, and an estimated 30% of cases of DCM are thought to be familial. 
Determination of the mode of inheritance of DCM in the Great Dane would enable 
breeders to identify individuals that should be eliminated from breeding. In addition, 
linkage approaches in the dog can help localize the search for genes, as well, by 
revealing regions in the genome that are coinherited with alleles causing a disease.  
Chapter II provides the results of a linkage study in a family of Great Danes in 
order to identify regions of the Great Dane genome that are linked to DCM.  This work 
revealed linkage of DCM to six different chromosomes (chromosomes 2, 7, 9, 25, 28, 
and 31). However, canine chromosome 2 warrants further investigation, because it 
contains a region which has no corresponding conserved segments in the human. 
Sequencing of one candidate gene, SGCG, was performed in order to determine its 
relationship to DCM. Unfortunately, no differences in sequences between affected and 
unaffected Great Danes were found. Furthermore, the sequence from Great Danes was 
compared to the Boxer reference sequence and revealed no differences. This work 
excluded the coding portions of SGCG as causative for DCM in Great Danes. 
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In summary, the domestic dog serves as a valuable model for human disease. The 
dog has historically been valued by humans for many reasons, not the least of which 
being a faithful companion. This work has evaluated DCM which causes significant 
mortality in many breeds as well as the human. Understanding DCM in the Great Dane 
may enhance our understanding of human DCM, but will undoubtedly also improve the 
lives of countless Great Danes. 
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